
Africa's shifting role in the global drug trade
Africa is increasingly transitioning from a transit point to a significant production hub for synthetic drugs, with Nigeria recently uncovering the country's largest methamphetamine laboratory.
For years, Africa was primarily known as a transit point for international drug trafficking networks. But recent drug seizures and laboratory discoveries show that illicit drugs are no longer only passing through African countries — they are increasingly being manufactured there.
Recent discoveries of methamphetamine laboratories in countries such as Nigeria, South Africa, Kenya and Mozambique have fueled concerns that Africa is becoming a significant production hub for synthetic drugs.
According to the UN Office on Drugs and Crime (UNODC), synthetic drug production increasingly involves transnational criminal networks and clandestine laboratories capable of supplying both local and international markets.
Nigeria's biggest meth lab bust
The debate gained new urgency this year after Nigeria's National Drug Law Enforcement Agency (NDLEA) dismantled what the agency described as the largest clandestine methamphetamine laboratory ever uncovered in the country.
The operation in Nigeria's southwestern Ogun State led to the arrest of 10 suspects, including three Mexican nationals whom the NDLEA said had been brought into the country to help manufacture methamphetamine.
NDLEA's chairman, Mohamed Buba Marwa, said officers seized more than 2.4 metric tons of methamphetamine, precursor chemicals and other materials with an estimated international market value of about $363 million (€312 million).
Why drug production is rising
Dokun Adedeji, co-founder of the Compassionate Care Recovery Initiative, said Nigeria's drug landscape has evolved significantly over the past decade.
He noted that authorities have uncovered dozens of smaller laboratories over the years, with meth production sites identified in multiple states.
According to the UNODC, increasing local drug consumption and the expansion of illicit drug markets have coincided with the growth of synthetic-drug production in West Africa.
Human cost and response
Adedeji described the impact of drug laboratories as "devastating and destructive," noting that substance abuse contributes to school dropouts, family breakdowns, mental health challenges and rising criminal activity.
The UNODC says young people are increasingly affected by drug-use disorders, with 34% of people receiving treatment for such disorders in Africa under the age of 25.
Nigeria's NDLEA has intensified enforcement efforts, while NGOs have stepped in with awareness campaigns. However, Adedeji argued that policies based solely on punishment often drive users underground, making it harder to identify and support people struggling with addiction.
UNODC and civil society groups advocate a broader response that includes stronger national policies, expanded rehabilitation services, workplace prevention programs and increased regional cooperation across West Africa.